Ultimovacs (ULTI) Income Statement

Click line-items for a historical chart and %

Recurring	167.03M
Services	29.97M
License
Total revenues	196.99M
Recurring	44.1M
Services	32.07M
License
Total cost of revenues	76.16M
Gross profit	120.83M
Sales and marketing	55.21M
Research and development	31.7M
General and administrative	25.28M
Total operating expenses	112.2M
Operating income	8.63M
Interest expense and other	-179K
Other income, net	111K
Total other (expense), net	-68K
Income from continuing operations before income taxes	8.56M
Provision for income taxes	-3.8M
Income from continuing operations
Loss from discontinued operations, net of income taxes
Net income (loss)	4.76M
Earnings from continuing operations (in dollars per share)
Loss from discontinued operations (in dollars per share)
Total (in dollars per share)	0.16
Earnings from continuing operations (in dollars per share)
Loss from discontinued operations (in dollars per share)
Total (in dollars per share)	0.16
Basic (in shares)	28.98M
Diluted (in shares)	30.48M

Entities mentioned with ULTI

View All Entities